Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||
| Net Income | -67,995 | -51,985 |
| Depreciation Amortization | 56 | 19 |
| Other Working Capital | -14,132 | -9,624 |
| Other Operating Activity | 7,320 | 15,962 |
| Operating Cash Flow | $-74,751 | $-45,628 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -9 | -586 |
| Investing Cash Flow | $-9 | $-586 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 334,031 | 149 |
| Other Financing Activity | 0 | 272,347 |
| Financing Cash Flow | $334,031 | $272,496 |
| Beginning Cash Position | 230,440 | 4,158 |
| End Cash Position | 489,711 | 230,440 |
| Net Cash Flow | $259,271 | $226,282 |
| Free Cash Flow | ||
| Operating Cash Flow | -74,751 | -45,628 |
| Capital Expenditure | -71 | -586 |
| Free Cash Flow | -74,822 | -46,214 |